Book Review of
Bad Blood
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Lynn's Review
Bad Blood was one of my favorite books of 2018. I picked it and started reading it and could not put it down. I read it in less than two days. This is one of those books that makes you realize that fact is often stranger than fiction. The story is fascinating and the writing is very well done.
This is one of those hard to believe real life stories. The people that were involved and the people that got convinced to invest in this company is amazing. The subject of the book deals with a lot of science, medical, and technology facts, but the author writes it in such a way that anyone can read this. The writing draws you in. If I didn’t know this was a true story, I would have thought I was reading fiction. It is that well done.